Medstart provides a medically supervised weight loss program combining GLP-1 receptor agonists with personalized coaching and digital tools. This approach helps individuals achieve sustainable weight reduction and improve health outcomes through physician-led consultations and a multidisciplinary care team.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals seeking effective and sustainable weight management often struggle with traditional methods that may not address the underlying biological factors contributing to obesity. This can lead to frustration and a lack of long-term success in achieving health goals.
Solution
Medstart offers a medically supervised weight loss program that integrates modern pharmacotherapy with personalized coaching and digital tools. The program utilizes GLP-1 receptor agonists, such as Wegovy and Mounjaro, to reduce appetite and increase satiety, supporting significant weight reduction. Patients receive tailored treatment plans, regular progress monitoring via a dedicated app, and access to a multidisciplinary team including doctors, nurses, dietitians, and psychologists. This comprehensive approach aims to facilitate sustainable weight loss and improve overall health outcomes.
Target Audience
The primary target audience includes adults with a BMI over 30, or a BMI over 27 with obesity-related comorbidities such as pre-diabetes, type 2 diabetes, hypertension, or sleep apnea, who are seeking a medically supported weight loss solution.
Features
- Prescription of GLP-1 receptor agonists (e.g., Wegovy, Mounjaro) for appetite suppression and increased satiety.
- Physician-led consultations to determine appropriate medication dosage and treatment plans based on BMI and co-morbidities.
- Integrated mobile application for progress tracking, secure communication with the treatment team, and access to educational resources.
- Personalized coaching and support from a team of healthcare professionals, including dietitians and psychologists, to address behavioral aspects of weight management.
- Structured tapering program to facilitate gradual cessation of medication and maintenance of weight loss.
- Health assessments including blood tests and digital consultations to ensure patient safety and treatment efficacy.
- Adherence to regulatory standards, with services approved by the Danish Patient Safety Authority.